Quality of life schizophrenia: Insight and subjective response to neuroleptics

Journal of Nervous and Mental Disease

Volumn 186, Issue 2, 1998, Pages 74-78

  Browne, Stephen ^a   Garavan, Jeanne ^a   Gervin, Maurice ^a   Roe, Mark ^a   Larkin, Conal ^b   O'Callaghan, Eadbhard ^a  

^a Cluain Mhuire Family Centre   (Ireland)

^b St John of God Hospitaller Services Ireland   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DYSPHORIA; FEMALE; HUMAN; MALE; QUALITY OF LIFE; SCHIZOPHRENIA;

ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; AWARENESS; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0031884785     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005053-199802000-00002     Document Type: Article

References (29)

1. Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, Gorman JM (1994) Awareness of illness in schizophrenia and mood disorders. Arch Gen Psychiatry 51:826-836.
2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (3rd ed, rev). Washington, DC: Author.
3. Atkinson JM, Coia DA, Gilmour WH, Harper JP (1996) The impact of education groups for people with schizophrenia on social functioning and quality of life. Br J Psychiatry 168:199-204.
4. Atkinson M, Zibin S, Chuang H (1997) Characterizing quality of life among patients with chronic mental illness: A critical examination of the self-report methodology. Am J Psychiatry 154:99-105.
5. Attkisson C, Cook J, Karno M, Lehman A, McGlashan TH, Meltzer HY, O'Connor M, Richardson D, Rosenblatt A, Wells K, Williams J (1992) Caring for people with severe mental disorders: Clinical services research. Schizophr Bull 18:561-626.
6. Awad AG (1993) Subjective response to neuroleptics in schizophrenia. Schizophr Bull 19:609-618.
7. Awad AG, Hogan TP (1994) Subjective response to neuroleptics and quality of life: Implications for treatment outcome. Acta Psychiatr Scand 89(Suppl. 380):27-31.
8. Barnes TRE, Kane JM (1996) Choosing between old and new antipsychotics. Curr Opin Psychiatry 9:41-44.
9. Bellack AS, Morrison RL, Wixted JT, Mueser KT (1990) An analysis of social competence in schizophrenia. Br J Psychiatry 156:809-818.
10. Birchwood M, Smith J, Drury V, Healy J, Macmillan, Slade M (1994) A self-report insight scale for psychosis: Reliability, validity and sensitivity to change. Acta Psychiatr Scand 89:62-67.
11. Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, Larkin C, O'Callaghan E (1996) Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 94:118-124.
12. Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, Larkin C, O'Callaghan E (1997) A preliminary report on the effect of a psychosocial and educative programme on quality of life and symptomatology in schizophrenia. Eur Psychiatry 11:386-389.
13. Casey DE (1994) Motor and mental aspects of acute extrapyramidal syndromes. Acta Psychiatr Scand 89(Suppl. 380):14-20.
14. Davis JM (1976) Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 33:858-860.
15. Heinrichs DW, Hanlon ET, Carpenter WT Jr (1984) The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10:388-398.
16. Hogan TP, Awad AG (1992) Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 22:347-352.
17. Hogan TP, Awad AG, Eastwood R (1983) A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychol Med 13:177-183.
18. Kane JM (1996) Schizophrenia. N Engl J Med 334:34-39.
19. Lehman AF, Postrado LT, Rachuba LT (1993) Convergent validation of quality of life assessments for persons with severe mental illnesses. Qual Life Res 2:327-333.
20. Lewander T (1994) Neuroleptics and the neuroleptic-induced deficit syndrome. Acta Psychiatr Scand 89(Suppl. 380):8-13.
21. Malm U, May P, Dencker S (1981) Evaluation of the quality of life of the schizophrenic outpatient: a checklist. Schizophr Bull 7:477-484.
22. Martin C (1996) Impact of olanzapine on quality of life in schizophrenia. Eur Psychiatry 11(Suppl. 4):252.
23. Meltzer HY, Burnett S, Bastani B, Ramirez LF (1990) Effects of six months clozapine treatment on the quality of life of chronic schizophrenic patients. Hasp Commun Psychiatry 41: 892-897.
24. O'Boyle C (1994) The schedule for the evaluation of individual lity of life. Int J Ment Health 23:3-23.
25. Sainfort FS, Becker M, Diamond R (1996) Judgments of quality of life of individuals with severe mental disorders: Patient self-report versus provider perspectives. Am J Psychiatry 153: 497-502.
26. Schooler NR (1991) Maintenance medication for schizophrenia: Strategies for dose reduction. Schizophr Bull 17:311-324.
27. Schooler NR (1994) Deficit symptoms in schizophrenia: Negative symptoms versus neuroleptic-induced deficits. Acta Psychiatr Scand 89(Suppl. 380):21-26.
28. Van Putten T, May PRA (1978) Subjective response as a predictor of outcome in pharmacotherapy. Arch Gen Psychiatry 35: 477-480.
29. Van Putten T, May PRA, Marder SR, Wittman LA (1981) Subjective response to antipsychotic drugs. Arch Gen Psychiatry 38: 187-190.